Allogene Therapeutics (ALLO) Peer Comparison

$0.64

up-down-arrow $-0.03 (-4.35%)

As on 20-Nov-2026 12:33EST

Market cap

info icon

$291 Mln

Revenue (TTM)

info icon

$5 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Edit peer-selector-edit
Allogene Therapeutics (ALLO) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Halozyme Therapeutics (HALO)
Market cap ($ Mln)
291 18,292 18,064 16,837 11,432
Revenue ($ Mln)
5 2,838 1,208 2,497 1,802
Net Profit ($ Mln)
-174.46 517.83 890.37 885.14 485.42
Net Margin (%)
-3,759.98 18.24 73.69 35.45 26.93
RoE (%)
-51.97 87.53 88.40 46.96 --
Price to Earnings
-- 36.31 18.11 20.66 25.19
Price-To-Book
0.73 31.41 10.44 9.18 97.15

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...